B-Tg(mCar12) MC38

• 321899

B-Tg(mArtn) MC38
B-Tg(mCcl2) MC38

B-Tg(mCar12) MC38

Product nameB-Tg(mCar12) MC38
Catalog number321899
Strain backgroundC57BL/6
AliasesCa12; CA-XII; AI314958;2310047E01Rik
TissueColon
DiseaseColon carcinoma
SpeciesMouse
ApplicationB-Tg(mCar12) MC38 cells have the capability to establish tumors in vivo

on this page

  • Description
  • Targeting strategy
  • Tumorigenicity

Posters

View All

    Publication

      Description

      The exogenous promoter and mouse Car12 coding sequence were inserted into the mouse genome randomly. Mouse Car12 is highly expressed on the surface of B-Tg(mCar12) MC38 cells.
       

      Targeting strategy

      Gene targeting strategy for B-Tg(mCar12) MC38 cells. The exogenous promoter and mouse Car12 coding sequence were inserted into the mouse genome randomly.

      Tumor growth curve & Body weight changes

      Subcutaneous homograft tumor growth of B-Tg(mCar12) MC38 cells. B-Tg(mCar12) MC38 cells (5x105) and wild-type MC38 cells (5x105) were subcutaneously implanted into C57BL/6 mice (female, 9-week-old). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B) Body weight (Mean ± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-Tg(mCar12) MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.

      Tumor growth curve of individual curve

      B-Tg(mCar12) MC38 tumor growth of individual mice. B-Tg(mCar12) MC38 cells (5x105) and wild-type MC38 cells (5x105) were subcutaneously implanted into C57BL/6 mice (female, 9-week-old). As shown in panel, B-Tg(mCar12) MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.